Semi-Annual Statement Of Cash Flows

BrightPath Biotherapeutics Co., Ltd. - Filing #7585095

Concept 2022-04-01 to
2022-09-30
As at
2022-09-30
As at
2022-03-31
As at
2021-09-30
2021-04-01 to
2021-09-30
As at
2021-03-31
Semi-annual statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-809,792,000 JPY
-722,710,000 JPY
Depreciation
8,359,000 JPY
16,934,000 JPY
Impairment losses
JPY
3,667,000 JPY
Interest and dividend income
-11,000 JPY
JPY
Increase (decrease) in provision for retirement benefits
805,000 JPY
-1,404,000 JPY
Decrease (increase) in trade receivables
16,506,000 JPY
227,000 JPY
Increase (decrease) in trade payables
-63,000 JPY
-395,000 JPY
Other, net
198,200,000 JPY
-41,424,000 JPY
Subtotal
-585,995,000 JPY
-749,523,000 JPY
Interest and dividends received
13,000 JPY
14,000 JPY
Interest paid
-202,000 JPY
JPY
Income taxes paid
-2,420,000 JPY
-2,420,000 JPY
Net cash provided by (used in) operating activities
-588,604,000 JPY
-751,928,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
JPY
-11,293,000 JPY
Net cash provided by (used in) investing activities
JPY
-11,293,000 JPY
Cash flows from financing activities
Redemption of bonds
-87,500,000 JPY
JPY
Purchase of treasury shares
0 JPY
JPY
Net cash provided by (used in) financing activities
197,491,000 JPY
228,683,000 JPY
Net increase (decrease) in cash and cash equivalents
-391,113,000 JPY
-534,538,000 JPY
Cash and cash equivalents
1,913,913,000 JPY
2,305,026,000 JPY
2,730,849,000 JPY
3,265,388,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.